CARMAT SAS
36, avenue de l’Europe
78941 Vélizy Villacoublay
Cedex
CS 40533
France
Tel: 33-0-1-3945-6450
Fax: 33-0-1-3945-6451
Website: http://www.carmatsas.com/
Email: contact@carmatsas.com
78 articles about CARMAT SAS
-
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
-
Biopharma and life sciences companies from across the globe provide updates. Belgium-based Galapagos NV won European approval for Jyseleca for the treatment of adult patients with moderately to severely active ulcerative colitis (UC).
-
French artificial heart maker Carmat announced Tuesday that it had successfully implanted its Aeson artificial heart into the chest cavity of a 57-year-old woman.
-
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations including Takeda, Origin Therapeutics, ERS Genomics and more.
-
Biopharma companies from around the globe provide updates on their businesses and pipelines.
-
BioSpace Movers & Shakers, May 14
5/14/2021
Biopharma and life sciences companies strengthen their leadership teams and boards with Movers & Shakers. -
Truffle Capital Reports Outstanding 2020 Stock Market Performance for Its Listed BioMedTech Portfolio Companies
2/1/2021
Three companies founded or co-founded by Truffle represent 30% of the total valuation of the highest BioMedTech market caps of Euronext Paris. They are also among the 2020 top stock performers.
-
Clinical Catch-Up: October 19-23
10/26/2020
It was another busy week for clinical trial updates and news. Here’s a look. -
BioSpace Global Roundup, May 28
5/28/2020
Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses. -
BioSpace Global Roundup, May 14
5/14/2020
Biopharma and life sciences companies from across the globe provide updates on their pipeline and business. -
BioSpace Global Roundup, April 9
4/9/2020
Biopharma companies from across the globe provide updates to their business operations and pipelines. -
BioSpace Global Roundup: Feb. 6
2/6/2020
Pharma and life science companies from across the globe provide updates on their pipelines and businesses. -
BioSpace Global Roundup, Dec. 5
12/5/2019
Companies from across the globe provide updates on their business and pipelines. -
BioSpace Global Roundup, Nov. 21
11/21/2019
Companies from across the globe provide updates on their businesses and pipelines. -
BioSpace Global Roundup, Nov. 7
11/7/2019
Biotech and pharmaceutical companies from across the globe provide updates on their business and pipelines. -
BioSpace Global Roundup, Aug. 29
8/29/2019
Companies from across the globe provide updates on their business and pipelines. -
CARMAT presents positive interim results of the first part of its PIVOTAL study
1/15/2019
CARMAT today announced an update on its clinical progress and recent developments, as well as its cash position at December 31, 2018.
-
The European Investment Bank supports CARMAT with €30 million for the marketing process of its total artificial heart
12/17/2018
CARMAT and the European Investment Bank today announce the signing of a €30 million loan agreement supported by the European Fund for Strategic Investments (EFSI)
-
BioSpace Movers and Shakers: Dec. 17
12/17/2018
With the year closing out, biotech and pharma companies are making adjustments to their leadership ranks and boards of directors. -
CARMAT Announces the Appointment of Pascale d’arbonneau as Chief Financial Officer
12/12/2018
CARMAT today announces the appointment of Pascale d’Arbonneau as Chief Financial Officer.